Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience.

PubWeight™: 5.12‹?› | Rank: Top 1%

🔗 View Article (PMID 11451829)

Published in Chest on July 01, 2001

Authors

M Biffi1, G Boriani, L Frabetti, G Bronzetti, A Branzi

Author Affiliations

1: Institute of Cardiology, University of Bologna, Bologna, Italy.

Articles citing this

Persistent left superior vena cava with absent right superior vena cava: a case report and review of the literature. Cardiovasc J Afr (2010) 1.82

Persistent left superior vena cava: review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients. World J Surg Oncol (2011) 1.74

Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation. Heart Vessels (2009) 1.66

A novel method of placing right ventricular leads in patients with persistent left superior vena cava using a conventional j stylet. Indian Pacing Electrophysiol J (2014) 1.52

Hypoxia caused by persistent left superior vena cava connecting to the left atrium a rare clinical entity. Tex Heart Inst J (2012) 1.05

Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol (2009) 1.02

Prevalence of associated cardiovascular abnormalities in 500 patients with aortic coarctation referred for cardiovascular magnetic resonance imaging to a tertiary center. Pediatr Cardiol (2011) 1.01

Left superior caval vein: a powerful indicator of fetal coarctation. Heart (2005) 1.01

Implantation of pacemaker for sick sinus syndrome in a patient with persistent left superior vena cava and absent right superior vena cava. Heart Vessels (2008) 0.94

Cardiac resynchronization therapy for patients with congenital heart disease: technical challenges. J Interv Card Electrophysiol (2012) 0.91

Transvenous defibrillator implantation in a patient with persistent left superior vena cava. World J Cardiol (2013) 0.91

Persistent left superior vena cava: diagnosed by bedside echocardiography in a liver transplant patient: a case report. Korean J Anesthesiol (2014) 0.90

Cardiac defibrillator implantation via persistent left superior vena cava - sometimes this approach is facile. A case report. Arch Med Sci (2011) 0.86

Vena caval anomalies. J Clin Imaging Sci (2013) 0.85

Persistent Left Superior Vena Cava Draining into the Coronary Sinus: A Case Report. Cardiol Res (2011) 0.83

Cardiac resynchronization therapy in a patient with persistent left superior vena cava draining into the coronary sinus and absent innominate vein: a case report and review of literature. Indian Pacing Electrophysiol J (2014) 0.83

High prevalence rate of left superior vena cava determined by echocardiography in patients with congenital heart disease in Saudi Arabia. Libyan J Med (2013) 0.82

Persistent left superior vena cava: a reason for pseudodisplacement of a port catheter. Surg Radiol Anat (2003) 0.81

Persistent Left Superior Vena Cava in Patients Undergoing Cardiac Device Implantation: Clinical and Long-Term Data. Cardiol Res (2013) 0.80

Side matters: An intriguing case of persistent left superior vena-cava. World J Clin Cases (2013) 0.80

Minimally invasive video-assisted thoracoscopic left ventricular epicardial lead implantation for biventricular pacing in a patient with persistent left superior vena cava. Heart Vessels (2008) 0.78

CRT-D Implantation Through a Persistent Left Superior Vena Cava. Indian Pacing Electrophysiol J (2014) 0.78

Giant coronary sinus. Tex Heart Inst J (2011) 0.77

Mitral valve repair in patient with absent right superior vena cava in visceroatrial situs solitus. J Cardiothorac Surg (2013) 0.75

Persistent left superior vena cava draining into the left atrium. BMJ Case Rep (2013) 0.75

Perforation of the right ventricle during cardiac resynchronisation therapy upgrade not related to a coexisting persistent left superior vena cava. BMJ Case Rep (2012) 0.75

A Rare Association of Sinus Venosus-Type Atrial Septal Defect and Persistent Left Superior Vena Cava Detected by Transthoracic Echocardiography and Cardiac Magnetic Resonance Imaging. Am J Case Rep (2015) 0.75

Transcatheter treatment of patent foramen ovale combined with abnormal drainage of left superior vena cava to left upper pulmonary vein. J Cardiovasc Ultrasound (2013) 0.75

Persistent left superior vena cava diagnosed during pacemaker implantation. Neth Heart J (2002) 0.75

What's in a Name? Utilization of the Innominate Vein for Pacemaker Lead Placement in the Setting of Persistent Left Superior Vena Cava. Cureus (2017) 0.75

PCI techniques to aid implantation of CRT-D in a senior patient with persistent left superior vena cava. J Geriatr Cardiol (2016) 0.75

Left superior vena cava, a remnant of embryological development. Neth Heart J (2008) 0.75

A huge echolucent structure resembling cyst adjacent to left atrium: Revealing persistent left superior vena cava with 4D echocardiography. Indian Heart J (2016) 0.75

Persistent left superior vena cava mistaken for nodal metastasis: a case report. J Med Case Rep (2010) 0.75

Left Atrial Drainage of a Persistent Left Superior Vena Cava. Radiol Case Rep (2015) 0.75

Ultrasound-guided catheterization of the left subclavian vein without recognition of persistent left superior vena cava: A case report. Medicine (Baltimore) (2017) 0.75

Retaining of PTCA guide wire in the left ventricular lead and subsequent application of epicardial electrode when CRT-D implantation in a patient with severe heart failure and persistent left superior vena cava: a case report. Int J Clin Exp Med (2015) 0.75

Tracking the path traversed by temporary pacing lead. Indian Heart J (2012) 0.75

Raghib Syndrome Presenting as a Cryptogenic Stroke: Role of Cardiac MRI in Accurate Diagnosis. Case Rep Cardiol (2015) 0.75

Persistent Left Superior Vena Cava in Hematological Malignancy Requiring Central Venous Catheter Insertion for Intensive Chemotherapy. Case Rep Oncol (2015) 0.75

All is not lost, when lead goes in the wrong direction. Indian Pacing Electrophysiol J (2007) 0.75

Epicardial CRT-P- and S-ICD Implantation in a Young Patient with Persistent Left Superior Vena Cava. Herzschrittmacherther Elektrophysiol (2016) 0.75

Persistent left superior vena cava: an unusual but conquerable obstacle in device implantation. Clin Res Cardiol (2009) 0.75

Single and dual chamber pacemaker implantation in patients with left superior vena cava persistence - own experiences. Postepy Kardiol Interwencyjnej (2017) 0.75

Permanent pacemaker implantation via left superior vena cava without communication with the coronary sinus. J Interv Card Electrophysiol (2009) 0.75

Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? HeartRhythm Case Rep (2016) 0.75

Articles by these authors

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med (2000) 4.04

Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group. Lancet (1995) 2.05

Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. Eur Heart J (2004) 1.66

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation (1994) 1.61

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57

Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53

Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42

Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study. Europace (1999) 1.41

Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn (1997) 1.40

[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39

Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet (2003) 1.13

Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09

Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J (2001) 1.09

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07

A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06

Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04

Pulmonary arterial hypertension associated to connective tissue diseases. Lupus (2005) 1.03

Laminopathies: many diseases, one gene. Report of the first Italian Meeting Course on Laminopathies. Acta Myol (2011) 1.01

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol (1994) 0.99

Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99

Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking. Pacing Clin Electrophysiol (2000) 0.99

Genetic effects of PR toxin in eukaryotic microorganisms. Environ Mutagen (1979) 0.98

Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98

Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97

Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol (2001) 0.96

Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart (2008) 0.93

Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol (1995) 0.92

Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery. Heart (2006) 0.92

Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91

Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study. J Interv Card Electrophysiol (2001) 0.91

Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin. Br Heart J (1990) 0.90

[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. Cardiologia (1989) 0.89

Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med (2001) 0.88

Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics (2001) 0.86

Genetic and metabolic effects of gluconasturtiin, a glucosinolate derived from cruciferae. Mutat Res (2004) 0.86

Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest (1998) 0.85

Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients. J Heart Lung Transplant (2001) 0.85

Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents. Handb Exp Pharmacol (2006) 0.85

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes. Am J Cardiol (1993) 0.85

Paroxysmal atrial fibrillation in sleep. Sleep (1997) 0.85

Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet (2005) 0.84

Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol (1992) 0.84

Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84

Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom (2001) 0.83

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83

Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol (1999) 0.83

Assessment of antimutagenicity and anticarcinogenicity. Mutat Res (1992) 0.83

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82

Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxide. Mutat Res (1976) 0.82

The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J (2002) 0.82

Genetic heterogeneity of hypertrophic cardiomyopathy. Int J Cardiol (1985) 0.82

Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82

Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract (2007) 0.81

Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol (1993) 0.81

Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct (1990) 0.81

Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol (1997) 0.81

Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. Am J Transplant (2013) 0.81

Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart (2005) 0.81

Drugs, surgery, cardioverter defibrillator: a decision based on the clinical problem. Pacing Clin Electrophysiol (1993) 0.80

Genotoxic and mono-oxygenase system effects of the fungicide maneb. Arch Toxicol (2000) 0.80

A PHACES syndrome unmasked by propranolol interruption in a tetralogy of Fallot patient: case report and extensive review on new indications of beta blockers. Curr Med Chem (2014) 0.80

Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial. Circulation (1993) 0.80

Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses. Eur J Clin Pharmacol (1986) 0.80

Tocainide and metoprolol: an efficacious therapeutic combination in the treatment of premature ventricular beats. Clin Cardiol (1989) 0.79

Cytochrome P-450 inducibility by ethanol and 7-ethoxycoumarin O-deethylation in S. cerevisiae. Biochem Biophys Res Commun (1984) 0.79

Evaluation of atrial refractoriness and atrial fibrillation inducibility immediately after internal cardioversion in patients with chronic persistent atrial fibrillation. Cardiovasc Drugs Ther (1999) 0.79

Induction of gene mutations and gene conversions by vinyl chloride metabolites in yeast. Cancer Res (1977) 0.79

Comparative haemodynamic effects of transdermal vs intravenous nitroglycerin in acute myocardial infarction with elevated pulmonary artery wedge pressure. Eur Heart J (1990) 0.79

Usefulness of transesophageal echocardiographic monitoring to improve the outcome of stent-graft treatment of thoracic aortic aneurysms. Am J Cardiol (2001) 0.79

Effects of wave reflection timing on left ventricular mechanics. J Biomech (1999) 0.78

Electrophysiologic properties of prenalterol. Int J Cardiol (1983) 0.78

Usefulness of nicorandil in congestive heart failure. Am J Cardiol (1990) 0.78

Flecainide: evidence of non-linear kinetics. Eur J Clin Pharmacol (1991) 0.78

Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response. Arch Gerontol Geriatr (2008) 0.78

Biochemical and genetic interactions of two commercial pesticides with the monooxygenase system and chlorophyllin. J Environ Pathol Toxicol Oncol (1996) 0.78

Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplant Proc (2006) 0.78

Effects of cinnamaldehyde on survival and formation of HGPRT- mutants in V79 cells treated with methyl methanesulfonate, N-nitroso-N-methylurea, ethyl methanesulfonate and UV light. Mutat Res (1994) 0.78

Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol (1995) 0.78

[Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy]. Cardiologia (1988) 0.78

Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin. J Heart Lung Transplant (2000) 0.78

Expenditure and value for money: the challenge of implantable cardioverter defibrillators. QJM (2009) 0.78

[Cerebral and renal aspergillosis in a patient with orthotopic heart transplant: diagnosis, treatment and follow-up]. Cardiologia (1989) 0.77

Predictors of atrial defibrillation threshold in internal cardioversion. Pacing Clin Electrophysiol (2000) 0.77

[Restenosis after coronary angioplasty: its pathogenesis and prevention]. Cardiologia (1991) 0.77

Ultrasound determination of left ventricular position for volume angiography. Chest (1972) 0.77

Ultrastructural and immunohistochemical contribution to the histogenesis of human cardiac myxoma. Ultrastruct Pathol (1988) 0.77